The drug Trikafta has changed the lives of many Canadians living with cystic fibrosis. But in many other parts of the world, the drug is either not available — or if it is, it costs hundreds of thousands of dollars a year. That’s why Cheri Nel, who is based in Johannesburg, is suing American pharmaceutical company Vertex over its patent and price tag.
How O.J. Simpson’s trial gripped the ‘90s
Protecting your money from hackers
What’s climate change doing to our brains?
Why birding is ‘quietly radical’
What we learned from Trudeau’s testimony
Prepping for devastating wildfires
Masculinity needs that ‘big dick energy’: Scott Galloway
Parents of school shooter convicted of manslaughter
Protecting Arctic sovereignty
Does intermittent fasting work?
A legal right to a family doctor?
False paternity tests ID wrong dads
A glimmer of hope for the Whitehorse Star
Scanning the skies for the total solar eclipse
Medical concerns about an anti-contraception movement, online and beyond
What dog attacks say about dog ownership culture
Innovating a way out of the housing crisis
How will animals react to the eclipse?
Aid workers fear for safety in Gaza
Inside a Gaza hospital
Create your
podcast in
minutes
It is Free
Front Burner
Vinyl Cafe
Ideas
Someone Knows Something
Under the Influence with Terry O’Reilly